Editorial Comment to Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: Assessment of protective effects in a rat model

International Journal of Urology

Volumn 19, Issue 12, 2012, Pages 1112-1113

  Damiano, Rocco ^a   Cicione, Antonio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GEMCITABINE; HYALURONIC ACID; MITOMYCIN C; PACLITAXEL;

ANIMAL MODEL; BACTERIAL LOAD; BCG VACCINATION; BIODEGRADATION; BLADDER CARCINOMA; CELL GROWTH; CLINICAL PRACTICE; DRUG EFFICACY; GENE ACTIVATION; GROWTH INHIBITION; HISTOPATHOLOGY; IN VITRO STUDY; INTERSTITIAL CYSTITIS; NONHUMAN; NOTE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RENAL PROTECTION; URINARY TRACT INFECTION; UROTHELIUM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHONDROITIN SULFATES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HYALURONIC ACID; URINARY TRACT INFECTIONS;

EID: 84870283763     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12033     Document Type: Note

References (7)

1. Tasdemir S, Tasdemir C, Vardi N etal. Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model. Int. J. Urol. 2012; 19: 1108-12.
2. Damiano R, Cicione A. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Ther. Adv. Urol. 2011; 3: 223-32.
3. Iavazzo C, Athanasiou S, Pitsouni E, Falagas ME. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? Eur. Urol. 2007; 51: 1534-40; discussion 1540-1.
4. Damiano R, Quarto G, Bava I etal. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur. Urol. 2011; 59: 645-51.
5. Ferro M, Giuberti G, Zappavigna S etal. Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms. Oncol. Rep. 2012; 27: 409-15.
6. Bassi PF, Volpe A, D'Agostino D etal. Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. J. Urol. 2011; 185: 445-9.
7. Nishimura M, Yan W, Mukudai Y etal. Role of chondroitin sulfate-hyaluronan interactions in the viscoelastic properties of extracellular matrices and fluids. Biochim. Biophys. Acta 1998; 1380: 1-9.